Dr. Luke D. Rothermel

Claim this profile

UH Seidman Cancer Center at Southwest General Hospital

Studies Skin Cancer
Studies Melanoma
2 reported clinical trials
4 drugs studied

Area of expertise

1Skin Cancer
Luke D. Rothermel has run 2 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Melanoma
Luke D. Rothermel has run 2 trials for Melanoma. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Affiliated Hospitals

Image of trial facility.
UH Seidman Cancer Center At Southwest General Hospital
Image of trial facility.
University Hospitals Parma Medical Center

Clinical Trials Luke D. Rothermel is currently running

Image of trial facility.

Surgical Excision Margins

for Melanoma

Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of life.
Recruiting2 awards Phase 39 criteria

More about Luke D. Rothermel

Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Luke D. Rothermel has experience with
  • Pembrolizumab
  • Therapeutic Conventional Surgery
  • Wide Local Excision = 1cm Margin
  • Wide Local Excision = 2cm Margin
Breakdown of trials Luke D. Rothermel has run
Skin Cancer
Melanoma
Cutaneous Melanoma

Other Doctors you might be interested in

Brenda W. CooperSeidman Cancer Center
Leland Metheny, MDUniversity Hospitals Cleveland Medical Center
Pedro M. BarataTulane Medical Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Luke D. Rothermel specialize in?
Luke D. Rothermel focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Luke D. Rothermel currently recruiting for clinical trials?
Yes, Luke D. Rothermel is currently recruiting for 1 clinical trial in Middleburg Heights Ohio. If you're interested in participating, you should apply.
Are there any treatments that Luke D. Rothermel has studied deeply?
Yes, Luke D. Rothermel has studied treatments such as Pembrolizumab, Therapeutic Conventional Surgery, Wide Local Excision = 1cm Margin.
What is the best way to schedule an appointment with Luke D. Rothermel?
Apply for one of the trials that Luke D. Rothermel is conducting.
What is the office address of Luke D. Rothermel?
The office of Luke D. Rothermel is located at: UH Seidman Cancer Center at Southwest General Hospital, Middleburg Heights, Ohio 44130 United States. This is the address for their practice at the UH Seidman Cancer Center at Southwest General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top